Skip to main content
SpringerLink
Log in

Release behavior of VAN from four types of CaP-ceramic granules using various loading methods at two different degrees of acidity

  • Delivery Systems
  • Original Research
  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

The release behavior of vancomycin (VAN) from beta-tricalciumphosphate (βTCP), hydroxyapatite (HA), glass ceramic (GC) and sponge-like collagen βTCP granule composite (sponge) was studied. Vacuum and drip loading methods were compared. The influence of VAN concentration and pH on release behavior was analyzed with respect to a stable release level of VAN above the minimum inhibitory concentration over 14 days. Initially the morphology of the granule carrier systems was examined with ESEM, stereomicroscopy, µCT-imaging and Camsizer® regarding porosity, interconnecting pores and granule size. Drug release patterns following a vacuum and a drip loading method with VAN at concentrations of 5 and 50 mg/ml were compared. The influence of pH 7.4 compared to pH 5.0 on release behavior was studied. The drug was released in bidistilled water at 37 °C, the concentration determined by photometry at 220 nm. For statistical purposes, the mean and standard deviation were calculated and analyzed by Origin 9.1 Professional SR1 (OriginLab). Due to low interconnectivity and low porosity, the vacuum loading method was unable to attain complete drug loading of the ceramic granules. The sponge showed an inhomogeneous distribution of βTCP granules. Drug release was high at pH 7.4, at pH 5.0 it practically did not occur. All samples except for the collagen-complex show an initial VAN burst release with a following steady release. Loading with 5 mg/ml concentrated VAN resulted in a higher percentage of available drug being released. However, when loaded with 50 mg/ml, the absolute amount of drug released was higher.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. König DP, Peters KM. Fortbildung Osteologie. Darmstadt: Steinkopff; 2006.

    Google Scholar 

  2. Holtom PD, Smith AM. Introduction to Adult Posttraumatic Osteomyelitis of the Tibia. Clin Orthop Relat Res. 1999;360:6–13. https://doi.org/10.1097/00003086-199903000-00003.

    Article  Google Scholar 

  3. Musil HE. Trauma und Carcinom?: Ursache und Folge der Osteomyelitis. Arch Orthop Unf-Chir. 1976;84:257–60. https://doi.org/10.1007/BF00416083.

    Article  Google Scholar 

  4. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-Joint Infections. N Engl J Med. 2004;351:1645–54. https://doi.org/10.1056/NEJMra040181.

    Article  Google Scholar 

  5. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422–9. https://doi.org/10.1056/NEJMra035415.

    Article  Google Scholar 

  6. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364:369–79. https://doi.org/10.1016/S0140-6736(04)16727-5.

    Article  Google Scholar 

  7. Niethard FU, Pfeil J, Biberthaler P. Orthopädie und Unfallchirurgie: 78 Tabellen; [inklusive Video CD-ROM]. 6th ed. Stuttgart: Thieme; 2009.

    Google Scholar 

  8. Zimmerli WFU. Classification and microbiology of osteomyelitis. Orthopade. 2004;33:267–72.

    Article  Google Scholar 

  9. Kayser et al. Medizinische Mikrobiologie. Stuttgart: Thieme; 2011.

  10. Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol. 1996;44:157–64.

    Article  Google Scholar 

  11. Leonova SN, Malyshev VV. Mechanisms of disturbance in regenerative processes in chronic traumatic osteomyelitis. Vestn Ross Akad Med Nauk. 2009;44:13–7.

    Google Scholar 

  12. Jesserer H. Knochenkrankheiten. München: Urban & Schwarzenberg; 1971.

    Book  Google Scholar 

  13. Chen W-H, Jiang L-S, Dai L-Y. Surgical treatment of pyogenic vertebral osteomyelitis with spinal instrumentation. Eur Spine J. 2007;16:1307–16. https://doi.org/10.1007/s00586-006-0251-4.

    Article  Google Scholar 

  14. Tetsworth K, Cierny G. Osteomyelitis Debridement Techniques. Clin Orthop Relat Res. 1999;360:87–96. https://doi.org/10.1097/00003086-199903000-00011.

    Article  Google Scholar 

  15. Kinik H, Karaduman M. Cierny-Mader Type III chronic osteomyelitis: the results of patients treated with debridement, irrigation, VAN beads and systemic antibiotics. Int Orthop. 2008;32:551–8. https://doi.org/10.1007/s00264-007-0342-9.

    Article  Google Scholar 

  16. Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg. 2004;188:57–66. https://doi.org/10.1016/S0002-9610(03)00292-7.

    Article  Google Scholar 

  17. Gentry LO. Management of osteomyelitis. Int J Antimicrob Agents. 1997;9:37–42.

    Article  Google Scholar 

  18. Becker DE, Reed KL, Essentials of local anesthetic pharmacology. Anesth Prog. 2006;53:98–109. https://doi.org/10.2344/0003-3006(2006)53[98:EOLAP]2.0.CO;2.

    Article  Google Scholar 

  19. Anand A, Pundir R, Pandian CS, Saraf S, GuptaH.Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis. Indian J Pharm Sci. 2009;71:377–81. https://doi.org/10.4103/0250-474X.57285.

    Article  Google Scholar 

  20. Frommelt L. Principles of systemic antimicrobial therapy in foreign material associated infection in bone tissue, with special focus on periprosthetic infection. Injury. 2006;37:S87–94. https://doi.org/10.1016/j.injury.2006.04.014.

    Article  Google Scholar 

  21. Walenkamp G, Vree T, van Rens T. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res. 1986;205:171–83.

    Google Scholar 

  22. Mayr HO, Suedkamp NP, Hammer T, Hein W, Hube R, Roth PV, Bernstein A. Beta-tricalcium phosphate for bone replacement: stability and integration in sheep. J Biomech. 2015;48:1023–31. https://doi.org/10.1016/j.jbiomech.2015.01.040

    Article  Google Scholar 

  23. Sailer HF, Weber FE. Knochenersatzmaterialie. Mund Kiefer Gesicht. 2000;4:384–91.

    Article  Google Scholar 

  24. LeGeros RZ. Calcium phosphates in oral biology and medicine. Basel, New York, NY: Karger; 1991.

    Google Scholar 

  25. McKee MD, Wild LM, Schemitsch EH, Waddell JP. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J Orthop Trauma. 2002;16:622–7.

    Article  Google Scholar 

  26. Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong). 2002;10:53–60.

    Article  Google Scholar 

  27. Otsuka M. Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties. J Biomed Mater Res. 1995;29:33–8.

    Article  Google Scholar 

  28. Radin S, Campbell J, Ducheyne P, Cuckler J. Calcium phosphate ceramic coating as VAN carriers. Biomaterials. 1997;18:777–82.

    Article  Google Scholar 

  29. Nandi SK, Mukherjee P, Roy S, Kundu B, De DK, Basu D. Local antibiotic delivery systems for the treatment of osteomyelitis – A review. Mater Sci Eng: C. 2009;29:2478–85. https://doi.org/10.1016/j.msec.2009.07.014.

    Article  Google Scholar 

  30. Kanellakopoulou K, Giamarellos-Bourboulis E. Carrier systems for the local delivery of antibiotics in bone infections. Drugs. 2000;59:1223.

    Article  Google Scholar 

  31. Epple M. Biomaterialien und Biomineralisation: Eine Einführung für Naturwissenschaftler, Mediziner und Ingenieure. Wiesbaden: Vieweg+Teubner Verlag; 2003.

    Book  Google Scholar 

  32. Uchida A, Nade S, McCartney E, Ching W. The use of ceramics for bone replacement. A comparative study of three different porous ceramics. J Bone Jt Surg Br. 1984;66:269–75.

    Article  Google Scholar 

  33. Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load bearing internal orthopedic applications. J Biomed Mater Res Symp. 1971;2:161–229.

    Article  Google Scholar 

  34. Lu J. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J Mater Sci Mater Med. 1999;10:111–20.

    Article  Google Scholar 

  35. Chang B. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials. 2000;21:1291–8.

    Article  Google Scholar 

  36. Baino F, Vitale-Brovarone C. Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future. J Biomed Mater Res A. 2011;97:514–35. https://doi.org/10.1002/jbm.a.33072.

    Article  Google Scholar 

  37. El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices. 2005;2:87–101. https://doi.org/10.1586/17434440.2.1.87.

    Article  Google Scholar 

  38. Kundu B, Lemos A, Soundrapandian C, Sen PS, Datta S, Ferreira JMF, Basu D. Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system. J Mater Sci Mater Med. 2010;21:2955–69. https://doi.org/10.1007/s10856-010-4127-0.

    Article  Google Scholar 

  39. Hidayat LK, Hsu D, Quist, Shriner R, Wong-Beringer KA, High-dose A. VAN therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006;166:2138–44. https://doi.org/10.1001/archinte.166.19.2138.

    Article  Google Scholar 

  40. Mader JT. Antibiotic therapy for musculoskeletal infections: American Volume. J Bone Jt Surg. 2001;83:1878–90.

    Article  Google Scholar 

  41. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73:121–36. https://doi.org/10.1016/S0168-3659(01)00248-6.

    Article  Google Scholar 

  42. El-Ghannam A, Jahed K, Govindaswami M. Resorbable bioactive ceramic for treatment of bone infection. J Biomed Mater Res A. 2010;94:308–16. https://doi.org/10.1002/jbm.a.32705.

    Article  Google Scholar 

  43. Silverman LD, Lukashova L, Herman OT, Lane JM, Boskey AL. Release of gentamicin from a tricalcium phosphate bone implant. J Orthop Res. 2007;25:23–9. https://doi.org/10.1002/jor.20284.

    Article  Google Scholar 

  44. Eitenmüller J. Die Freisetzungsverzögerung verschiedener Antibiotica aus resorbierbarem Tricalciumphosphat-Keramikgranulat durch die Verwendung löslicher Überzüge zur lokalen Behandlung der Osteomyelitis. Lange Arch für Chir. 1983;360:193–206. https://doi.org/10.1007/BF01259235.

    Article  Google Scholar 

  45. Seidenstücker M, Mrestani Y, Neubert RHH, Bernstein A, Mayr HO. Release kinetics and antibacterial efficacy of microporous -TCP coatings. J Nanomater. 2013;2013:1–8. https://doi.org/10.1155/2013/842951.

    Article  Google Scholar 

  46. Itokazu M, Yang W, Aoki T, Ohara A, Kato N. Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing. Biomaterials. 1998;19:817–9.

    Article  Google Scholar 

  47. Laurent F, Bignon A, Goldnadel J, Chevalier J, Fantozzi G, Viguier E, et al. A new concept of gentamicin loaded HAP/TCP bone substitute for prophylactic action: in vitro release validation. J Mater Sci Mater Med. 2008;19:947–51. https://doi.org/10.1007/s10856-007-0163-9.

    Article  Google Scholar 

  48. DiCicco M, Goldfinger A, Guirand F, Abdullah A, Jansen SA. In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system. J Biomed Mater Res Part B Appl Biomater. 2004;70:1–20. https://doi.org/10.1002/jbm.b.30014.

    Article  Google Scholar 

  49. Faigle G. Zur Antibiotikafreisetzung aus Calciumphosphat-Kermikgranulaten: Dissertation. School of Medicine, Universität Freiburg. Submitted. 2016.

  50. Curasan AG. Datenblatt CerasorbM®-Granulat. 2nd edn. 2007. http://curasaninc.com/products.

  51. Curasan AG. Datenblatt OsBone®. 3rd edn. 2009. http://curasaninc.com/products.

  52. Curasan AG. Datenblatt Osseolive®. 2nd edn. 2010. http://curasaninc.com/products.

  53. Curasan AG. Datenlatt CeraCell®. 5th edn. 2011. http://curasaninc.com/products.

  54. Pastorino D, Canal C, Ginebra M-P. Drug delivery from injectable calcium phosphate foams by tailoring the macroporosity–drug interaction. Acta Biomater. 2015;12:250–9. https://doi.org/10.1016/j.actbio.2014.10.031.

    Article  Google Scholar 

  55. Otsuki B, Takemoto M, Fujibayashi S, Neo M, Kokubo T, Nakamura T. Pore throat size and connectivity determine bone and tissue ingrowth into porous implants: three-dimensional micro-CT based structural analyses of porous bioactive titanium implants. Biomaterials. 2006;27:5892–900. https://doi.org/10.1016/j.biomaterials.2006.08.013.

    Article  Google Scholar 

  56. Canal C, Pastorino D, Mestres G, Schuler P, Ginebra MP. Relevance of microstructure for the early antibiotic release of fresh and pre-set calcium phosphate cements. Acta Biomater. 2013;9:8403–12. https://doi.org/10.1016/j.actbio.2013.05.016.

    Article  Google Scholar 

  57. Dorozhkin SV. Calcium orthophosphate cements for biomedical application. J Mater Sci. 2008;43:3028–57. https://doi.org/10.1007/s10853-008-2527-z.

    Article  Google Scholar 

  58. Seidenstücker M. Herstellung eines Kompositmaterials bestehend aus einer porösen ß-Tricalciumphosphatkeramik und einem Drug-Release-System mit kontinuierlicher Wirkstofffreisetzung [Dissertation]. Freiburg i. Br.: Albert-Ludwigs-Universität; 2015. https://doi.org/10.6094/UNIFR/10383.

  59. Kundu B, Soundrapandian C, Nandi SK, Mukherjee P, Dandapat N, Roy S, et al. Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial. Pharm Res. 2010;27:1659–76. https://doi.org/10.1007/s11095-010-0166-y.

    Article  Google Scholar 

  60. Sasaki T, Ishibashi Y, Katano H, Nagumo A, Toh S. In vitro elution of VAN from calcium phosphate cement. J Arthroplast. 2005;20:1055–9. https://doi.org/10.1016/j.arth.2005.03.035.

    Article  Google Scholar 

  61. Suchy T, Supova M, Klapkova E, Horny L, Ryglova S, Zaloudkova M, et al. The Sustainable release of VAN and its degradation products from nanostructured collagen/hydroxyapatite composite layers. J Pharm Sci. 2016;105:1288–94. https://doi.org/10.1016/S0022-3549(15)00175-6.

    Article  Google Scholar 

  62. Stigter M, Bezemer J, Groot K, de, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release. 2004;99:127–37. https://doi.org/10.1016/j.jconrel.2004.06.011.

    Article  Google Scholar 

  63. Brinkrolf P, Klaas C, Horn D. Medikationsfehler in der Intensivmedizin. Intensivmed up2date. 2015;11:125–40. https://doi.org/10.1055/s-0041-101463.

    Article  Google Scholar 

  64. Sedláček O, Studenovský M, Větvička D, Ulbrich K, Hrubý M. Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates. Bioorg & Med Chem. 2013;21:5669–72. https://doi.org/10.1016/j.bmc.2013.07.038.

    Article  Google Scholar 

Download references

Acknowledgements

The authors express their gratitude to Curasan for the provision of the materials. The authors also wish to thank Frank Syrowatka from the interdisciplinary center of materials science (CMAT) of the Martin Luther University of Halle for the EDX measurements. The authors extend their gratitude to Prof. Mülhaupt's group at the Freiburg Materials Research Center (FMF) for their support in measuring porosity as well as to Dr. Simon Procz at the Freiburg Materials Research Center (FMF) for the µCT measurements. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Orthopedics and Trauma Surgery, Medical Center - Albert-Ludwigs-University of Freiburg, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Hugstetterstr. 55, Freiburg, D-79106, Germany

    G. Faigle, A. Bernstein, N. P. Suedkamp, H. O. Mayr & M. Seidenstuecker

  2. Curasan AG, Lindigstr. 4, Kleinostheim, D-63801, Germany

    F. Peters & W. D. Huebner

Authors
  1. G. Faigle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. P. Suedkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. O. Mayr
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. D. Huebner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Seidenstuecker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Faigle.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faigle, G., Bernstein, A., Suedkamp, N.P. et al. Release behavior of VAN from four types of CaP-ceramic granules using various loading methods at two different degrees of acidity. J Mater Sci: Mater Med 29, 12 (2018). https://doi.org/10.1007/s10856-017-6006-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10856-017-6006-4

Search

Navigation